Inhalant abuse
- F18.1 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
- The 2025 edition of ICD-10-CM F18.1 became effective on October 1, 2024.
- This is the American ICD-10-CM version of F18.1 – other international versions of ICD-10 F18.1 may differ.
Type 1 Excludes
- inhalant dependence (F18.2-)
- inhalant use, unspecified (F18.9-)
The following code(s) above F18.1 contain annotation back-references
that may be applicable to F18.1:
Clinical Information
- Illicit use of chemicals and products whose vapors can be inhaled to produce a rapid mind-altering effect. Inhalants include aerosols, gases, and volatile solvents that are often inhaled repeatedly to achieve the short-lived intoxicating effect.
- Inhalation of vapors from volatile chemical substances (such as aerosol sprays, solvents, and anesthetics) in order to produce mind-altering effects.
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- 2024 (effective 10/1/2023): No change
- 2025 (effective 10/1/2024): No change
Code annotations containing back-references to F18.1:
- Type 1 Excludes: F18.2, F18.9